Compared with the control, TGF-β treatment in GSC 1123 and R39 cells induced AEBP1 expression, activated p-AKT (Figure 5A), and promoted cell proliferation (Figure 5B) and glioma sphere formation (Figure 5C). The gene discussed is TGFB1; the disease is central nervous system cancer.